We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Maker Concealed Collusive Activity From Investors, Shareholder Argues

Mealey's (November 9, 2016, 5:30 PM EST) -- NEW YORK — A pharmaceutical company and certain of its current and former executive officers misrepresented the company’s business and financial condition to investors and engaged in violations of federal antitrust...
To view the full article, register now.